Pharmacovigilance in developing countries

BMJ. 2007 Sep 8;335(7618):462. doi: 10.1136/bmj.39323.586123.BE.

Abstract

Requires collaboration between stakeholders to develop novel models of funding

Publication types

  • Editorial

MeSH terms

  • Adverse Drug Reaction Reporting Systems*
  • Developing Countries*
  • Global Health
  • Humans